VCP (valosin-containing protein) is crucial for maintaining mitochondrial function, and in prostate cancer cells, it employs self-aggregation to inhibit mitochondrial activity, thereby evading cell death during nutrient deprivation and promoting malignancy [32]. Here, VCP is linked to prostate carcinoma.